Holen Sie sich die Stockscreener-App
0.0197
7.26%
0.0754
Schlusskurs vom Vortag:
$0.0951
Offen:
$0.018
24-Stunden-Volumen:
1.64M
Relative Volume:
95.64
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.92M
KGV:
-0.000264
EPS:
-74.5891
Netto-Cashflow:
$-16.08M
1W Leistung:
+7.26%
1M Leistung:
-98.11%
6M Leistung:
-99.97%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.018
$0.0249
1-Wochen-Bereich:
$0.018
$0.0249
52-Wochen-Spanne:
$0.018
$0.0249
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
Firmenname
Cero Therapeutics Holdings Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare CERO vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
0.0197 | 0 | 0 | -19.92M | -16.08M | -74.59 |
VRTX
Vertex Pharmaceuticals Inc
|
436.47 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
635.50 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
811.00 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.51 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
153.84 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Hochstufung | D. Boral Capital | Hold → Buy |
Cero Therapeutics Holdings Inc Aktie (CERO) Neueste Nachrichten
CEROW | CERO THERAPEUTICS WTS 29 Insider Trading - Quiver Quantitative
Maxim Group Initiates Coverage of CERo Therapeutics Holdings (CERO) with Buy Recommendation - MSN
CERo Therapeutics (OTCQB: CERO) registers 729.6M common shares; 10-Q updates show cash, loss - Stock Titan
CERo Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TradingKey - TradingKey
CERo completes second cohort dosing in phase 1 trial - Investing.com UK
CERo completes second cohort dosing in phase 1 trial By Investing.com - Investing.com Nigeria
Experimental CAR-T for blood cancers moves to higher dose - Stock Titan
MSN Money - MSN
CERo Therapeutics Raises Capital via Convertible Note Financing - TipRanks
CERo Therapeutics Raises $400,000 via 10% Convertible Note From Keystone, Up to $1M - TradingView
[424B3] CERO THERAPEUTICS HOLDINGS, INC. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
[8-K] CERO THERAPEUTICS HOLDINGS, INC. Reports Material Event - Stock Titan
CERo Therapeutics (CERO) registers 729.6M common shares in S-1 supplement - Stock Titan
Insider ownership and executive pay at CERo Therapeutics (NASDAQ: CERO) - Stock Titan
Cero Therapeutics registers up to 12.5M shares for potential sale under equity agreement with Keystone - MSN
CERo Therapeutics Holdings, Inc. announced that it has received $0.4 million in funding from Keystone Capital Partners LLC - marketscreener.com
CERO Therapeutics (CERO) director receives stock options for 1.82M shares - Stock Titan
CERO Therapeutics (CERO) director files Form 3 ownership - Stock Titan
CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial - ADVFN
CERO SEC FilingsCERo Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
CERo Therapeutics: Advancing Next-Generation Engineered T Cell Immunotherapy for Cancer Treatment - Minichart
729.6M-share registration — CERo Therapeutics Holdings (OTCQB: CERO) - Stock Titan
CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
CERo Therapeutics Secures Convertible Note Financing Facility - TipRanks
CERO Therapeutics (CERO) adds up to $1M via new convertible note - Stock Titan
CERo expands blood cancer trial after sixth patient dose - Stock Titan
Aug Weekly: Is CERo Therapeutics Holdings Inc exposed to currency risks2026 Reactions & Stock Market Timing Techniques - baoquankhu1.vn
Chipmakers Recap: Is CERo Therapeutics Holdings Inc Equity Warrant stock showing strong momentumWeekly Gains Report & Verified Entry Point Detection - baoquankhu1.vn
Trend Recap: What is CERo Therapeutics Holdings Inc Equity Warrants valuation compared to sectorTrade Volume Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn
CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial - ADVFN
US Stocks Recap: Can Fifth Era Acquisition Corp I sustain its profitabilityQuarterly Profit Report & AI Based Trade Execution Alerts - baoquankhu1.vn
EV Market: Can CERo Therapeutics Holdings Inc be recession proofSwing Trade & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Aug PreEarnings: What is CERo Therapeutics Holdings Inc Equity Warrants revenue forecast2026 Gainers & Daily Momentum Trading Reports - baoquankhu1.vn
CERo Therapeutics Holdings, Inc. announced that it has received $0.35 million in funding - marketscreener.com
Quarterly Trades: What is CERo Therapeutics Holdings Inc Equity Warrants revenue forecast2026 Major Catalysts & Smart Swing Trading Techniques - baoquankhu1.vn
Insider Buy: Is CGEM subject to activist investor interestWeekly Gains Summary & Fast Moving Stock Watchlists - baoquankhu1.vn
Aug Update: Is CERo Therapeutics Holdings Inc Equity Warrant benefiting from interest rate changes2026 Closing Moves & Weekly High Return Stock Opportunities - baoquankhu1.vn
CERo Therapeutics Delays 2025 Annual Report Filing - TipRanks
CERo Therapeutics (NASDAQ: CERO) delays 2025 10-K; preliminary $19.9M loss - Stock Titan
History Review: What is CERo Therapeutics Holdings Inc Equity Warrants valuation compared to sector - baoquankhu1.vn
Can CERo Therapeutics Holdings Inc. deliver consistent dividends2026 Levels & Reliable Intraday Trade Plans - baoquankhu1.vn
Portfolio Update: Is CERo Therapeutics Holdings Inc Equity Warrant part of any ETFWeekly Trade Recap & Proven Capital Preservation Methods - baoquankhu1.vn
Aug Chart Watch: Can CERo Therapeutics Holdings Inc deliver consistent dividends - baoquankhu1.vn
Aug Selloffs: Will CERo Therapeutics Holdings Inc Equity Warrant announce a stock split2026 Snapshot & Technical Pattern Based Buy Signals - baoquankhu1.vn
CEO Moves: Will InspireMD Inc stock hit new highs in YEAR2026 Sentiment & Proven Capital Preservation Methods - baoquankhu1.vn
Dividend Watch: Is CERo Therapeutics Holdings Inc Equity Warrant stock showing strong momentum2026 Market WrapUp & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Market Review: What is CERo Therapeutics Holdings Inc Equity Warrants valuation compared to sectorEarnings Beat & Growth Focused Stock Pick Reports - baoquankhu1.vn
If You Invested $1,000 in CERo Therapeutics (CERO) - Stock Titan
Earnings Update: What is the target price for HOVRW stock2026 Top Decliners & Verified Momentum Stock Ideas - baoquankhu1.vn
VIX Spike: Can CERo Therapeutics Holdings Inc Equity Warrant outperform in the next rally2026 Bull vs Bear & Long-Term Safe Return Strategies - baoquankhu1.vn
Finanzdaten der Cero Therapeutics Holdings Inc-Aktie (CERO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.25%
0.46%
Kapitalisierung:
|
Volumen (24h):